
| Specifications | |
| Business section |

| Specifications | |
| Suggested Link Details/Purchase | |
| Content | Last CloseIndustrySector 6.49 USDMedical DevicesHealthcare Accuray, Inc. ARAY (NAS) Morningstar Equity Research ©2009 Morningstar. All Rights Reserved. Unless otherwise provided in a separate agreement, you may use this report only in the country in which its original distributor is based. Data as originally reported. The information contained herein is not represented or warranted to be accurate, correct, complete, or timely. This report is for information purposes only, and should not be considered a solicitation to buy or sell any security. Redistribution is prohibited without written permission. To order reprints, call +1 312-696-6100. To license the research, call +1 312-696-6869. Pricing data through 02 Mar 2012Accuray, Inc. was incorporated in California in 1990 and commenced operations in 1992. The Company was reincorporated in 2007 in Delaware. It develops a commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. CyberKnife system represents the next generation of radiosurgery systems, combining continuous image- guidance technology with a compact linear accelerator, or linac that has the ability to move in three dimensions according to a patient s treatment plan. The firm s image- guidance technology continuously acquires images to track a tumor s location and transmits any position corrections to the robotic arm prior to delivery of each dose of radiation. Accuray s linac is a compact radiation treatment device that uses microwaves to accelerate electrons to create high- energy X-ray beams to destroy the tumor. This combination extends the benefits of radiosurgery to the treatment of tumors anywhere in the body. The CyberKnife system autonomously tracks, detects and corrects for tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation typically with sub-millimeter accuracy. The CyberKnife procedure requires no anesthesia, can be performed on an outpatient basis and allows for the treatment of patients who otherwise would not have been treated with radiation or who may not have been good candidates for surgery. In addition, the CyberKnife procedure avoids many of the potential risks and complications that are associated with other treatment options and is more cost effective than traditional surgery. The CyberKnife system received U.S. Food and Drug Administration, or FDA, 510(k) clearance in July 1999 to provide treatment planning and image-guided robotic radiosurgery for tumors in the head and neck. In August 2001, the CyberKnife system received 510(k) clearance to treat tumors anywhere in the body where radiation treatment is indicated. The CyberKnife system has also received a CE mark for sale in Europe and has been approved for various indications in Japan, Korea, Taiwan, China and other countries. In Europe, Japan, Korea, Taiwan, and China, the CyberKnife system has received approval to provide treatment planning and image-guided robotic radiosurgery for tumors anywhere in the body where radiation treatment is indicated. Profile Contents Profile Contents In addition to this comprehensive company profile, Morningstar offers in-depth analyst research and ratings on selected companies. For information about our full analyst coverage, please contact: Morningstar Equity Research +1 (312) 696-6869 nasdaqrequest@morningstar.com Company Profile Company Data Management & Ownership Industry Focus 1 2 3 4 Page 1 of 5 |
| Navigation | Previous Page / Next Page |
| Suggested Link Details/Purchase | |
| Following Datasheets | ARBA_USA (6 pages) ARCP_USA (5 pages) AREE0061 (1 pages) AREE0074 (1 pages) AREE0078 (1 pages) AREE0079 (1 pages) AREE0087 (1 pages) AREE008D (1 pages) AREE0098 (1 pages) AREE009E (1 pages) |
Check in e-portals![]() |
World-H-News Products Extensions Partners Automation Jet Parts |
| Sitemap Folder | group1 group2 group3 group4 group5 group6 group7 group8 group9 group10 group11 group12 group13 group14 group15 group16 group17 group18 group19 group20 group21 group22 group23 group24 group25 group26 group27 group28 group29 group30 group31 group32 group33 group34 group35 group36 group37 group38 group39 group40 group41 group42 group43 group44 group45 group46 group47 group48 group49 group50 group51 group52 group53 group54 group55 group56 group57 group58 group59 group60 group61 group62 group63 group64 group65 group66 group67 group68 group69 group70 group71 group72 group73 group74 group75 group76 group77 group78 group79 group80 group81 group82 group83 group84 group85 group86 group87 group88 group89 group90 group91 group92 group93 group94 group95 group96 group97 group98 group99 group100 Prewious Folder Next Folder |